Novel formulations

Details for Australian Patent Application No. 2007226899 (hide)

Owner 3M Innovative Properties Company Glaxo Group Limited

Inventors Stefely, James; Riley, Trevor; Capecchi, John

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007226899

PCT Pub. Number WO2007/109698

Priority 60/784,634 22.03.06 US

Filing date 21 March 2007

Wipo publication date 27 September 2007

International Classifications

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61L 2/23 (2006.01) Disinfection or sterilising

Event Publications

25 September 2008 PCT application entered the National Phase

  PCT publication WO2007/109698 Priority application(s): WO2007/109698

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007226901-Cannula stabilization seal

2007226896-Extended capability transfer between a user equipment and a wireless network